Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • going1green going1green Oct 14, 2013 11:44 AM Flag

    Brian Nichols " Pimavanserin: The Most Underestimated Blockbuster In Biotechnology " LINK

    Seeking Alpha By: Brian Nichols 10/14/13
    Pimavanserin: The Most Underestimated Blockbuster In Biotechnology
    The bottom line is that as time passes, expect estimates to rise quickly for pima, which will then drive the valuation for Acadia. The current market potential for pima simply does not reflect the valuation of the PDP indication let alone ADP and Schzo. Therefore, unprecedented gains are likely. And for those of you hoping for a buyout or a substantial partnership, I'd cross your fingers and pray that management does not yet
    entertain such offers. Due to the disruptive nature of pima, many leading pharmaceutical companies are going to lose billions because of pima, which means Acadia is likely already speaking with or is being assessed by a handful of large companies. However, this is a company that simply has too much upside for a 100% premium right now, and over the next year as peak sales estimate rise, you will see that any price under $50 is cheap

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACAD
32.13-0.27(-0.83%)3:03 PMEDT